Friday, October 2, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 21, 2026

Qualcomm Stockholders Back Board, Equity Plan; CEO Amon Highlights AI, Robotics and Data Center Push

View original at finance.yahoo.com
Qualcomm Stockholders Back Board, Equity Plan; CEO Amon Highlights AI, Robotics and Data Center Push Qualcomm logo Key Points Stockholders approved all board-recommended items including the election of 11 directors, ratification of PwC as auditor, approval of the amended 2023 long-term incentive plan with a 24 million…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Qualcomm is diversifying beyond handsets into personal AI, wearables, PCs, automotive, edge networking and industrial IoT

    60% confidence

  • Qualcomm expects data center revenue to become financially material in fiscal 2027

    60% confidence

  • Qualcomm has formally entered advanced robotics with Dragonwing IQ 10 series support for AMRs and humanoids

    60% confidence

  • Qualcomm is returning approximately 100% of free cash flow to shareholders

    60% confidence

Data points we hold from this source

Qualcomm Incorporated · dividend per share increase0.03 USD
Qualcomm Incorporated · board size11 directors
Qualcomm Incorporated · free cash flow return rate100 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
Qualcomm Stockholders Back Board, Equity Plan; CEO Amon Highlights AI, Robotics and Data Center Push — Source | Via News | Finance Via News